Dicina57101116/s1, Figure S1: Time course of LSS-symptom for six-year duration; Subjects without either knee or hip OA in 2004, Table S1: Transform of LSS-symptoms positive and Hydroxystilbamidine bis medchemexpress LSSsymptoms adverse groups by age; Subjects with no either knee or hip or OA, Table S2: Adjust in Medicina 2021, 57, x FOR PEER Evaluation scores of your subjects with/without LSS symptoms; Subjects with no either of 15 or hip OA 13 knee RDQ in 2004, Table S3: Alterations in eight domains of SF-36 of your subjects with/without LSS symptom; Subjects without either knee or hip or OA, Table S4: Predictive things for LSS-symptom TMPyP4 Telomerase presence Supplementary Supplies: The period; are out there on the web at www.mdpi/xxx/s1, Figure at the end of six-year follow-upfollowing Subjects without the need of either knee or hip or OA, Table S5: Table S5.S1: Time courselegLSS-symptomresulting induration; Subjects with out either knee or hip follow-up period; Risk ratio of of symptoms for six-year LSS improvement during the six-year OA in 2004, Table S1: Modify of LSS-symptoms positive and LSS-symptoms negative groups by age; SubSubjects devoid of either knee or hip or OA,S2: Modify in RDQ scores of the on the operation for LSS for the duration of Table S6: Predictive factors subjects with/without jects devoid of either knee or hip or OA, Table theLSS symptoms; Subjects withoutSubjects without either knee or hipChanges in eight domains six-year follow-up period; either knee or hip OA in 2004, Table S3: or OA. Author Contributions: Conceptualization, K.O.the finish of six-year follow-up period;information curation, K.O.; S4: Predictive elements for LSS-symptom presence at and S.-i.K. (Shin-ichi Kikuchi); Subjects formal analysis,knee or funding acquisition, K.O. and S.-i.K. (Shin-ichi Kikuchi); investigation, K.O., without either K.O.; hip or OA, Table S5: Table S5. Threat ratio of leg symptoms resulting in LSS development during the six-year follow-up K.O.; Subjects with no either knee or hip or OA, Table T.N., K.W., K.K. and H.K.; methodology, period;project administration, K.O.; supervision, S.-i.K. (ShinS6: Predictive factors on the operation for LSS for the duration of writing–original period; ; Subjects S.-i.K. ichi Kikuchi), S.Y. and S.-i.K. (Shin-ichi Konno); the six-year follow-updraft, K.O. and with- (Shin-ichi out either knee or hip or OA. Konno); writing–review and editing, S.-i.K. (Shin-ichi Kikuchi) and S.Y. All authors have study and agreed to Contributions: Conceptualization, K.O. and S.-i.K. (Shin-ichi Kikuchi); information curation, K.O.; the published version of your manuscript. Authorformal This research was acquisition, a grant in the Fukushima investigation, K.O., Funding:evaluation, K.O.; funding funded byK.O. and S.-i.K. (Shin-ichi Kikuchi);Society for the Promotion of T.N., K.W., K.K., and H.K.; methodology, K.O.; project administration, K.O.; supervision, S.-i.K. Medicine and also a Grant from Fukushima Prefectural Hospitals. (Shin-ichi Kikuchi), S.Y., and S.-i.K. (Shin-ichi Konno); writing–original draft, K.O. and S.-i.K. (Shin-ichi Konno); writing–review and editing, study was carried out as outlined by the have Institutional Assessment Board Statement: TheS.-i.K. (Shin-ichi Kikuchi) and S.Y. All authorsguidelines with the read and agreed towards the published version of your manuscript. Medicine and also a Grant from Fukushima Prefectural Hospitals. of SF-36 on the subjects with/without LSS symptom; Subjects without either knee or hip or OA, TableDeclaration of Helsinki, and approved by the Ethics Committee of Fukushima Healthcare University Funding: This res.